Visualizing stem cells in vivo using magnetic resonance imaging.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Regenerative Medicine

Background:

• Stem cell (SC) therapies show promise but face challenges in clinical translation due to inconsistent trial results.
• Effective monitoring of SC migration and engraftment in vivo is essential for successful cell therapy.
• Longitudinal tracking of SCs is critical for optimizing treatment and improving clinical outcomes.

Purpose of the Study:

• To review and emphasize the importance of in vivo monitoring of SC distribution and fate post-implantation.
• To explore current contrast agents for tracking mesenchymal stem cells (MSCs) using MRI.
• To highlight MRI as a suitable non-invasive imaging modality for SC tracking.

Main Methods:

• Review of current literature on SC tracking using MRI.
• Discussion of various contrast agents (CAs) for MRI-based SC tracking.
• Focus on positive CAs (e.g., gadolinium), negative CAs (e.g., superparamagnetic iron oxides), and 19F tracers.

Main Results:

• MRI allows non-invasive and repeated observation of SCs in vivo.
• Contrast agents enable detection and tracking of implanted SCs.
• Different types of CAs offer distinct advantages for SC monitoring.

Conclusions:

• In vivo tracking of SCs using MRI is vital for understanding cell behavior and optimizing therapeutic strategies.
• The choice of contrast agent impacts the ability to monitor SC migration, homing, and engraftment.
• Advanced imaging techniques are key to advancing SC therapy translation and clinical success.